Clinical trial
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in…
NCT00376233 · University of Jena, Other · Completed
Key facts
| NCT number | NCT00376233 |
|---|---|
| Title | Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia |
| Official title | First Detailed Study on Effects of Long Term Regular Cannabis Use on Arachidonic Acid-Prostaglandine Pathways in Schizophrenia |
| Lead sponsor | University of Jena, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia, Cannabis Abuse |
| Enrollment | 100 |
| Start date | Feb 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 14, 2006 |
| Last update posted | Oct 12, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: